Genolution Inc. (KOSDAQ:225220)
South Korea
· Delayed Price · Currency is KRW 2,045.00
-60.00 (-2.85%)
At close: Dec 5, 2025
Genolution Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -8,059 | -6,826 | -5,512 | 14,602 |
| Depreciation & Amortization | 2,416 | 2,041 | 1,578 | 1,328 |
| Loss (Gain) From Sale of Assets | 26.05 | - | 2,577 | -218.54 |
| Asset Writedown & Restructuring Costs | 25 | 17 | 141.55 | - |
| Loss (Gain) From Sale of Investments | 2,837 | 3,118 | -542.13 | 459.01 |
| Loss (Gain) on Equity Investments | - | 103.43 | -382.21 | 144.85 |
| Provision & Write-off of Bad Debts | 96.51 | 133.42 | -66.02 | 123.94 |
| Other Operating Activities | -2,804 | 334.95 | -113.97 | -5,301 |
| Change in Accounts Receivable | -370.23 | 24.11 | 1,412 | 5,192 |
| Change in Inventory | -715.37 | -582.32 | 705.03 | -2,178 |
| Change in Accounts Payable | 444.38 | 167.59 | -126.35 | -313.37 |
| Change in Other Net Operating Assets | -1,129 | 35.96 | -806.85 | -287.99 |
| Operating Cash Flow | -7,232 | -1,433 | -1,136 | 13,551 |
| Capital Expenditures | -1,202 | -12,125 | -6,805 | -22,506 |
| Sale of Property, Plant & Equipment | -3.3 | - | 2.5 | 115.38 |
| Sale (Purchase) of Intangibles | -112.71 | -61.22 | -78.65 | 642.92 |
| Investment in Securities | 27,818 | 37,294 | -279.52 | -29,700 |
| Other Investing Activities | 3.06 | 630.1 | 80 | -9.61 |
| Investing Cash Flow | 26,453 | 25,688 | -7,078 | -51,457 |
| Short-Term Debt Issued | - | 4,500 | 17,800 | - |
| Long-Term Debt Issued | - | 19,500 | - | 15,000 |
| Total Debt Issued | 24,000 | 24,000 | 17,800 | 15,000 |
| Short-Term Debt Repaid | - | -9,000 | -8,800 | - |
| Long-Term Debt Repaid | - | -15,187 | -63.74 | -2,040 |
| Total Debt Repaid | -24,321 | -24,187 | -8,864 | -2,040 |
| Net Debt Issued (Repaid) | -320.58 | -186.69 | 8,936 | 12,960 |
| Repurchase of Common Stock | - | - | -2,016 | -2,000 |
| Dividends Paid | - | - | - | -1,810 |
| Other Financing Activities | 292.06 | 559.9 | 238.21 | -0 |
| Financing Cash Flow | -28.52 | 373.2 | 7,159 | 9,150 |
| Foreign Exchange Rate Adjustments | 1,585 | 1,463 | -161.96 | 2,141 |
| Miscellaneous Cash Flow Adjustments | - | 0 | - | 0 |
| Net Cash Flow | 20,778 | 26,091 | -1,217 | -26,615 |
| Free Cash Flow | -8,434 | -13,558 | -7,940 | -8,955 |
| Free Cash Flow Margin | -92.22% | -190.00% | -81.34% | -23.51% |
| Free Cash Flow Per Share | -466.85 | -750.87 | -432.81 | -474.38 |
| Cash Interest Paid | 808.01 | 393.37 | 738.46 | 348.31 |
| Cash Income Tax Paid | - | -859.89 | 290.58 | 6,661 |
| Levered Free Cash Flow | -6,702 | -15,004 | -8,593 | - |
| Unlevered Free Cash Flow | -6,185 | -14,742 | -8,593 | - |
| Change in Working Capital | -1,770 | -354.66 | 1,184 | 2,413 |
Source: S&P Capital IQ. Standard template. Financial Sources.